503 related articles for article (PubMed ID: 25955444)
1. Risk factors for post-ERCP pancreatitis and hyperamylasemia: A retrospective single-center study.
He QB; Xu T; Wang J; Li YH; Wang L; Zou XP
J Dig Dis; 2015 Aug; 16(8):471-8. PubMed ID: 25955444
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic stents for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis should be inserted up to the pancreatic body or tail.
Sugimoto M; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Irie H; Watanabe K; Nakamura J; Kikuchi H; Waragai Y; Takasumi M; Hikichi T; Ohira H
World J Gastroenterol; 2018 Jun; 24(22):2392-2399. PubMed ID: 29904246
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic temporary 3F pancreatic duct stent to prevent post-ERCP pancreatitis in patients with a difficult biliary cannulation: a multicenter, prospective, randomized study.
Lee TH; Moon JH; Choi HJ; Han SH; Cheon YK; Cho YD; Park SH; Kim SJ
Gastrointest Endosc; 2012 Sep; 76(3):578-85. PubMed ID: 22771100
[TBL] [Abstract][Full Text] [Related]
4. Post-ERCP pancreatitis and hyperamylasemia: patient-related and operative risk factors.
Christoforidis E; Goulimaris I; Kanellos I; Tsalis K; Demetriades C; Betsis D
Endoscopy; 2002 Apr; 34(4):286-92. PubMed ID: 11932783
[TBL] [Abstract][Full Text] [Related]
5. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T
World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for post-ERCP pancreatitis in high risk patients who have undergone prophylactic pancreatic duct stenting: a multicenter retrospective study.
Ito K; Fujita N; Kanno A; Matsubayashi H; Okaniwa S; Nakahara K; Suzuki K; Enohara R;
Intern Med; 2011; 50(24):2927-32. PubMed ID: 22185981
[TBL] [Abstract][Full Text] [Related]
7. Is prophylactic somatostatin effective to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis or hyperamylasemia? A randomized, placebo-controlled pilot trial.
Wang ZK; Yang YS; Cai FC; Wang YH; Shi XL; Ding C; Li W
Chin Med J (Engl); 2013 Jul; 126(13):2403-8. PubMed ID: 23823808
[TBL] [Abstract][Full Text] [Related]
8. Risk factors associated with the development of hyperamylasemia and post-ERCP pancreatitis in the Cuban National Institute.
Hernández Garcés HR; Almeida Linnet A; Abreu Vázquez M; Calzadilla Bertot L; Peña K; Andrain Sierra Y; Moutary I; Segura Fernández N
Rev Gastroenterol Peru; 2014 Apr; 34(2):127-32. PubMed ID: 25028902
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for postendoscopic retrograde cholangiopancreatography pancreatitis: a retrospective analysis of 7,168 cases.
Zhou W; Li Y; Zhang Q; Li X; Meng W; Zhang L; Zhang H; Zhu K; Zhu X
Pancreatology; 2011; 11(4):399-405. PubMed ID: 21894057
[TBL] [Abstract][Full Text] [Related]
10. Randomized controlled trial of pancreatic stenting to prevent pancreatitis after endoscopic retrograde cholangiopancreatography.
Kawaguchi Y; Ogawa M; Omata F; Ito H; Shimosegawa T; Mine T
World J Gastroenterol; 2012 Apr; 18(14):1635-41. PubMed ID: 22529693
[TBL] [Abstract][Full Text] [Related]
11. Role of immunosuppression in post-endoscopic retrograde cholangiopancreatography pancreatitis after liver transplantation: a retrospective analysis.
Law R; Leal C; Dayyeh BA; Leise MD; Balderramo D; Baron TH; Cardenas A
Liver Transpl; 2013 Dec; 19(12):1354-60. PubMed ID: 24115362
[TBL] [Abstract][Full Text] [Related]
12. Analysis of risk factors and prevention strategies of post-ERCP pancreatitis.
Lin Y; Liu X; Cao DQ; Tang JH; Wen JJ; Li TF; Liu PF; Xia TS
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5185-5190. PubMed ID: 29228432
[TBL] [Abstract][Full Text] [Related]
13. Effect of somatostatin on prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis and hyperamylasemia: A systematic review and meta-analysis.
Wang G; Xiao G; Xu L; Qiu P; Li T; Wang X; Wen P; Wen J; Xiao X
Pancreatology; 2018 Jun; 18(4):370-378. PubMed ID: 29550097
[TBL] [Abstract][Full Text] [Related]
14. Effects of Somatostatin and Indomethacin Mono or Combination Therapy on High-risk Hyperamylasemia and Post-pancreatitis Endoscopic Retrograde Cholangiopancreatography Patients: A Randomized Study.
Wu Z; Xiao G; Wang G; Xiong L; Qiu P; Tan S
Surg Laparosc Endosc Percutan Tech; 2023 Oct; 33(5):474-479. PubMed ID: 37523580
[TBL] [Abstract][Full Text] [Related]
15. Needle-knife sphincterotomy: factors predicting its use and the relationship with post-ERCP pancreatitis (with video).
Bailey AA; Bourke MJ; Kaffes AJ; Byth K; Lee EY; Williams SJ
Gastrointest Endosc; 2010 Feb; 71(2):266-71. PubMed ID: 20003969
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for complications of ERCP in primary sclerosing cholangitis.
Ismail S; Kylänpää L; Mustonen H; Halttunen J; Lindström O; Jokelainen K; Udd M; Färkkilä M
Endoscopy; 2012 Dec; 44(12):1133-8. PubMed ID: 23108808
[TBL] [Abstract][Full Text] [Related]
17. Predictive factors for post-ERCP pancreatitis: a large-scale single expertized endoscopist study.
Katsinelos P; Lazaraki G; Gkagkalis S; Chatzimavroudis G; Fasoulas K; Zavos C; Pilpilidis I; Germanidis G; Kountouras J
Surg Laparosc Endosc Percutan Tech; 2014 Dec; 24(6):512-6. PubMed ID: 24732733
[TBL] [Abstract][Full Text] [Related]
18. Selective biliary cannulation techniques for endoscopic retrograde cholangiopancreatography procedures and prevention of post- endoscopic retrograde cholangiopancreatography pancreatitis.
Mukai S; Itoi T
Expert Rev Gastroenterol Hepatol; 2016 Jun; 10(6):709-22. PubMed ID: 26782710
[TBL] [Abstract][Full Text] [Related]
19. The number of wire placement in the pancreatic duct and metal biliary stent as risk factors for post-endoscopic retrograde cholangiopancreatography pancreatitis.
Shin SH; So H; Cho S; Kim N; Baik GH; Lee SK; Park DH
J Gastroenterol Hepatol; 2020 Jul; 35(7):1201-1207. PubMed ID: 31830336
[TBL] [Abstract][Full Text] [Related]
20. What is the most adapted indication of prophylactic pancreatic duct stent within the high-risk group of post-endoscopic retrograde cholangiopancreatography pancreatitis? Using the propensity score analysis.
Takenaka M; Fujita T; Sugiyama D; Masuda A; Shiomi H; Sugimoto M; Sanuki T; Hayakumo T; Azuma T; Kutsumi H
J Hepatobiliary Pancreat Sci; 2014 Apr; 21(4):275-80. PubMed ID: 24039185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
